- Reuters•5 days ago
The company, which produces almost half of the world's insulin, said the guarantee applied to Least Developed Countries as defined by the United Nations, other low-income nations as defined by the World Bank, and selected organizations providing relief in humanitarian situations. "We guarantee that we will provide low-priced human insulin to ensure access to quality treatments for patients in the poorest parts of the world for many years to come," the company said in a statement. Novo promised that the cost of the medicine would not exceed 20 percent of the list prices charged for human insulin in developed nations.
- Bloomberg•7 days ago
More than 30 years after diabetics began injecting themselves with the modern form of insulin, treatments in a pill seem as elusive as ever.
Novo Nordisk A/S (NONOF)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||44.24 - 45.00|
|52wk Range||44.24 - 46.40|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||20.97|
|Avg Vol (3m)||110,183|
|Dividend & Yield||1.41 (3.19%)|